MX6174E - Procedimiento para la preparacion de(4-trifluorometil)-anilida de acido 5-metil-isoxazol-4-carboxilico - Google Patents

Procedimiento para la preparacion de(4-trifluorometil)-anilida de acido 5-metil-isoxazol-4-carboxilico

Info

Publication number: MX6174E
Authority: MX; Mexico
Prior art keywords: anilida; carboxilico; trifluorometil; isoxazol; methyl
Prior art date: 1978-12-16

Application number

MX798546U

Other languages

English (en)

Inventor

Friedrich-Johannes Kammerer

Rudolf Schleyerbach

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-12-16

Filing date

1979-12-13

Publication date

1984-12-04

1979-12-13 Application filed by Hoechst Ag filed Critical Hoechst Ag

1984-12-04 Publication of MX6174E publication Critical patent/MX6174E/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Lubricants (AREA)
Chemical And Physical Treatments For Wood And The Like (AREA)

MX798546U 1978-12-16 1979-12-13 Procedimiento para la preparacion de(4-trifluorometil)-anilida de acido 5-metil-isoxazol-4-carboxilico MX6174E (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19782854439 DE2854439A1 (de)	1978-12-16	1978-12-16	Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung

Publications (1)

Publication Number	Publication Date
MX6174E true MX6174E (es)	1984-12-04

Family

ID=6057414

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
MX798546U MX6174E (es)	1978-12-16	1979-12-13	Procedimiento para la preparacion de(4-trifluorometil)-anilida de acido 5-metil-isoxazol-4-carboxilico
MX8403A MX8403A (es)	1978-12-16	1984-03-12	Procedimiento para la preparacion de (4-trifluro metil)-anilida de acido 5 metil-isoxasol-4-carboxilico.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
MX8403A MX8403A (es)	1978-12-16	1984-03-12	Procedimiento para la preparacion de (4-trifluro metil)-anilida de acido 5 metil-isoxasol-4-carboxilico.

Country Status (25)

Country	Link
US (2)	US4284786A (es)
EP (1)	EP0013376B1 (es)
JP (1)	JPS5583767A (es)
AR (2)	AR222680A1 (es)
AT (1)	ATE1067T1 (es)
AU (1)	AU529341B2 (es)
BG (1)	BG60764B2 (es)
CA (1)	CA1129867A (es)
DE (2)	DE2854439A1 (es)
DK (1)	DK149886C (es)
EG (1)	EG13926A (es)
ES (2)	ES486750A1 (es)
FI (1)	FI64154C (es)
GR (1)	GR72731B (es)
HU (1)	HU178015B (es)
IE (1)	IE49126B1 (es)
IL (1)	IL58951A (es)
LU (1)	LU90466I2 (es)
MX (2)	MX6174E (es)
NL (1)	NL990037I1 (es)
NO (1)	NO148925C (es)
NZ (1)	NZ192400A (es)
PH (1)	PH16627A (es)
PT (1)	PT70596A (es)
ZA (1)	ZA796793B (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3247454A1 (de) *	1982-12-22	1984-06-28	Laboratorios Bago S.A., Buenos Aires	Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2538806B1 (fr) *	1982-12-30	1986-02-21	Bago Sa Labor	Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur
DE3534440A1 (de) *	1985-09-27	1987-04-02	Hoechst Ag	Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) *	1985-09-27	1993-12-07	Hoechst Aktiengesellschaft	Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
US4935434A (en) *	1988-01-26	1990-06-19	Bristol-Myers Company	Antiarthritic isoxazole-4-carboxamides
FR2662692B1 (fr) *	1990-05-30	1995-04-28	Novapharme	Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
US5258397A (en) *	1988-11-30	1993-11-02	Novapharme	3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
US5583150A (en) *	1989-08-18	1996-12-10	Alcon Laboratories, Inc.	5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
DD297328A5 (de)	1989-08-18	1992-01-09	��@��k��Kk��	5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) *	1990-02-02	1991-03-19	Syntex (U.S.A.) Inc.	4-isoxazolecarboxamide derivatives
US5108999A (en) *	1990-02-02	1992-04-28	Syntex (U.S.A.) Inc.	4-isoxazolecarboxamide derivatives
DE59010701D1 (de) *	1990-05-18	1997-05-22	Hoechst Ag	Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
US6133301A (en) *	1991-08-22	2000-10-17	Aventis Pharma Deutschland Gmbh	Pharmaceuticals for the treatment of rejection reactions in organ transplantations
DE4127737A1 (de) *	1991-08-22	1993-02-25	Hoechst Ag	Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
DE59407413D1 (de) *	1993-01-08	1999-01-21	Hoechst Ag	Verwendung von Leflunomid zur Hemmung von Interleukin 1 beta
EP0607774B1 (de) *	1993-01-08	1998-12-09	Hoechst Aktiengesellschaft	Verwendung von Leflunomid zur Hemmung von Interleukin 1 alpha
ATE174219T1 (de) *	1993-01-08	1998-12-15	Hoechst Ag	Verwendung von leflunomid zur hemmung von tumornekrosefaktor alpha
DE59407415D1 (de) *	1993-01-08	1999-01-21	Hoechst Ag	Verwendung von Leflunomid zur Hemmung von Interleukin 8
TW314467B (es) *	1993-03-31	1997-09-01	Hoechst Ag
DE4323636A1 (de) *	1993-07-15	1995-01-19	Hoechst Ag	Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
LT3589B (en)	1993-11-30	1995-12-27	Hoechst Ag	Using of known combination for treatment of rejection reaction by transplantation of organs
US5610173A (en) *	1994-01-07	1997-03-11	Sugen, Inc.	Formulations for lipophilic compounds
US5700823A (en) *	1994-01-07	1997-12-23	Sugen, Inc.	Treatment of platelet derived growth factor related disorders such as cancers
US6335356B1 (en)	1994-01-07	2002-01-01	Sugen, Inc.	Method of treating a patient by parenteral administration of a lipophilic compound
US5519042A (en) *	1994-01-13	1996-05-21	Hoechst Aktiengesellschaft	Method of treating hyperproliferative vascular disease
US5624946A (en) *	1994-07-05	1997-04-29	Williams; James	Use of leflunomide to control and reverse chronic allograft rejection
NZ293691A (en) *	1994-10-17	1999-07-29	Hoechst Japan	Use of a medicament containing an anilide compound for treatment of type i allergic diseases
US5721277A (en) *	1995-04-21	1998-02-24	Sugen, Inc.	Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en)	1995-06-01	2001-12-18	University Of California	Treatment of platelet derived growth factor related disorders such as cancers
DE19539638A1 (de) *	1995-10-25	1997-04-30	Hoechst Ag	Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19702988A1 (de) *	1997-01-28	1998-07-30	Hoechst Ag	Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
US6316479B1 (en)	1997-05-19	2001-11-13	Sugen, Inc.	Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
EP0987256B1 (de) *	1997-08-08	2001-10-17	Aventis Pharma Deutschland GmbH	Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid
US7691890B2 (en)	1998-03-11	2010-04-06	James W. Williams	Anti-viral uses of leflunomide products
US20050255071A1 (en) *	1998-12-10	2005-11-17	Aventis Pharma Deutschland Gmbh	Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
DE19908527C2 (de)	1999-02-26	2001-08-30	Aventis Pharma Gmbh	Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
US6566395B1 (en)	1999-05-25	2003-05-20	Biomedicines, Inc.	Methods of treating proliferative disorders
DE19960443C2 (de) *	1999-12-15	2002-05-08	Aventis Pharma Gmbh	Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen
IL149792A0 (en) *	1999-12-16	2002-11-10	Teva Pharma	Novel processes for making and a new crystalline form of leflunomide
EP1473035A1 (en) *	2000-02-15	2004-11-03	Teva Pharmaceutical Industries Ltd.	Leflunomide of high purity
SK12992002A3 (sk) *	2000-02-15	2003-05-02	Teva Pharmaceutical Industries Ltd.	Spôsob syntézy leflunomidu
US20020077485A1 (en) *	2000-08-14	2002-06-20	Ilya Avrutov	Micronized leflunomide
WO2002080897A1 (en)	2001-04-05	2002-10-17	Aventis Pharmaceuticals Inc.	Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
GB0123571D0 (en)	2001-04-05	2001-11-21	Aventis Pharm Prod Inc	Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
WO2003042193A1 (en) *	2001-11-09	2003-05-22	Geneva Pharmaceuticals, Inc.	Process for preparing 5-methylisoxazole-4-carboxylic-(4'-trifluoromethyl)-anilide
US20050158371A1 (en) *	2002-02-12	2005-07-21	Sumitomo Pharmaceuticals Co., Ltd.	Novel external agent
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
US20060024376A1 (en) *	2004-07-30	2006-02-02	The University Of Chicago	Methods and compositions for reducing toxicity associated with leflunomide treatment
KR20080038339A (ko) *	2005-08-31	2008-05-06	코와 가부시키가이샤	관절 류머티즘의 예방 및/또는 치료법
EP2125895B1 (en)	2007-02-02	2015-04-08	Vegenics Pty Ltd	Vegf receptor antagonists for treating organ transplant alloimmunity and arteriosclerosis
CN101817797B (zh) *	2009-02-26	2013-04-10	江苏亚邦爱普森药业有限公司	高纯度3-甲基-n-[4-(三氟甲基)苯基]-4-异噁唑甲酰胺的合成方法
US9205577B2 (en) *	2010-02-05	2015-12-08	Allergan, Inc.	Porogen compositions, methods of making and uses
US9138309B2 (en)	2010-02-05	2015-09-22	Allergan, Inc.	Porous materials, methods of making and uses
US11202853B2 (en) *	2010-05-11	2021-12-21	Allergan, Inc.	Porogen compositions, methods of making and uses
JOP20190207A1 (ar)	2017-03-14	2019-09-10	Actelion Pharmaceuticals Ltd	تركيبة صيدلانية تشتمل على بونيسيمود
JP2021519334A (ja)	2018-03-26	2021-08-10	クリアクリークバイオ，インコーポレイテッド	ジヒドロオロト酸デヒドロゲナーゼを阻害するための組成物および方法
KR20220151625A (ko)	2020-03-06	2022-11-15	액테리온 파마슈티칼 리미티드	뇌 부피 손실을 둔화시키는 방법
US20210308117A1 (en)	2020-03-20	2021-10-07	Clear Creek Bio, Inc.	Methods of treating viral infections using inhibitors of nucleotide synthesis pathways
WO2023062511A1 (en)	2021-10-11	2023-04-20	Actelion Pharmaceuticals Ltd	Methods of treating multiple sclerosis
US20240261268A1 (en)	2022-02-11	2024-08-08	Vanda Pharmaceuticals Inc.	Methods of slowing an increase in brain ventricular volume

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4087534A (en) *	1974-05-22	1978-05-02	David Ovadia	N-haloalkylmio urazole pesticides
ES448386A1 (es) *	1975-06-05	1978-04-16	Hoechst Ag	Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
DE2524959C2 (de) *	1975-06-05	1983-02-10	Hoechst Ag, 6000 Frankfurt	5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel
DE2654797A1 (de) *	1976-12-03	1978-06-08	Hoechst Ag	Verfahren zur herstellung von isoxazolderivaten

1978
- 1978-12-16 DE DE19782854439 patent/DE2854439A1/de not_active Withdrawn
1979
- 1979-12-11 ES ES486750A patent/ES486750A1/es not_active Expired
- 1979-12-11 ES ES486758A patent/ES486758A1/es not_active Expired
- 1979-12-12 EG EG748/79A patent/EG13926A/xx active
- 1979-12-13 AT AT79105142T patent/ATE1067T1/de active
- 1979-12-13 FI FI793899A patent/FI64154C/fi not_active IP Right Cessation
- 1979-12-13 MX MX798546U patent/MX6174E/es unknown
- 1979-12-13 US US06/103,551 patent/US4284786A/en not_active Expired - Lifetime
- 1979-12-13 EP EP79105142A patent/EP0013376B1/de not_active Expired
- 1979-12-13 DE DE7979105142T patent/DE2962929D1/de not_active Expired
- 1979-12-14 AR AR279310A patent/AR222680A1/es active
- 1979-12-14 HU HU79HO2201A patent/HU178015B/hu unknown
- 1979-12-14 AU AU53853/79A patent/AU529341B2/en not_active Expired
- 1979-12-14 IL IL58951A patent/IL58951A/xx unknown
- 1979-12-14 GR GR60761A patent/GR72731B/el unknown
- 1979-12-14 NZ NZ192400A patent/NZ192400A/xx unknown
- 1979-12-14 ZA ZA00796793A patent/ZA796793B/xx unknown
- 1979-12-14 IE IE2426/79A patent/IE49126B1/en active Protection Beyond IP Right Term
- 1979-12-14 PT PT70596A patent/PT70596A/pt active IP Right Revival
- 1979-12-14 JP JP16170079A patent/JPS5583767A/ja active Granted
- 1979-12-14 DK DK534279A patent/DK149886C/da active
- 1979-12-14 PH PH23418A patent/PH16627A/en unknown
- 1979-12-14 CA CA342,109A patent/CA1129867A/en not_active Expired
- 1979-12-14 NO NO794094A patent/NO148925C/no unknown
1981
- 1981-03-03 US US06/239,986 patent/US4351841A/en not_active Expired - Lifetime
- 1981-05-19 AR AR285378A patent/AR226894A1/es active
1984
- 1984-03-12 MX MX8403A patent/MX8403A/es unknown
1994
- 1994-02-23 BG BG098534A patent/BG60764B2/bg unknown
1999
- 1999-10-27 LU LU90466C patent/LU90466I2/fr unknown
- 1999-10-29 NL NL990037C patent/NL990037I1/nl unknown

Also Published As

Publication number	Publication date
FI793899A (fi)	1980-06-17
PT70596A (de)	1980-01-01
DK534279A (da)	1980-06-17
DE2854439A1 (de)	1980-07-03
IL58951A0 (en)	1980-03-31
FI64154B (fi)	1983-06-30
NZ192400A (en)	1982-02-23
NO794094L (no)	1980-06-17
PH16627A (en)	1983-12-05
IE792426L (en)	1980-06-16
IE49126B1 (en)	1985-08-07
IL58951A (en)	1984-01-31
DK149886B (da)	1986-10-20
GR72731B (es)	1983-12-01
EG13926A (en)	1982-09-30
ZA796793B (en)	1980-11-26
MX8403A (es)	1994-03-31
BG60764B2 (bg)	1996-02-29
LU90466I2 (fr)	2000-01-03
DK149886C (da)	1987-04-21
AR226894A1 (es)	1982-08-31
ATE1067T1 (de)	1982-06-15
FI64154C (fi)	1983-10-10
US4351841A (en)	1982-09-28
ES486750A1 (es)	1980-06-16
DE2962929D1 (en)	1982-07-08
HU178015B (en)	1982-02-28
AU529341B2 (en)	1983-06-02
JPH0133470B2 (es)	1989-07-13
CA1129867A (en)	1982-08-17
EP0013376A2 (de)	1980-07-23
NL990037I2 (nl)	2000-01-03
AR222680A1 (es)	1981-06-15
NL990037I1 (nl)	2000-01-03
NO148925C (no)	1984-01-11
US4284786A (en)	1981-08-18
EP0013376B1 (de)	1982-05-19
NO148925B (no)	1983-10-03
AU5385379A (en)	1980-06-19
EP0013376A3 (en)	1980-09-17
JPS5583767A (en)	1980-06-24
ES486758A1 (es)	1980-05-16

Publication	Publication Date	Title
MX6174E (es)	1984-12-04	Procedimiento para la preparacion de(4-trifluorometil)-anilida de acido 5-metil-isoxazol-4-carboxilico
MX5877E (es)	1984-08-16	Procedimiento para la preparacion de derivados del acido piridiloxifenoxi-alfa-propionico
ES487400A0 (es)	1980-11-01	Procedimiento para la fabricacion de acido metacrilico
AR225363A1 (es)	1982-03-15	Procedimiento para la preparacion de acido alfa-hidroxi-gamma-metilmercaptobutirico
MX7101E (es)	1987-06-24	Procedimiento para la preparacion de derivados de acido quinolin-carboxilico
ES486198A0 (es)	1980-11-01	Procedimiento para la obtencion de compuestos de acido aminotiazolacetamino-3-cefem-4-carboxilico
AR223663A1 (es)	1981-09-15	Procedimiento para la preparacion de derivados 1,6-disustituidos de acido 4-piridon-3-carboxilico
MX5006E (es)	1983-02-09	Procedimiento para la preparacion de acido ciclohexancarboxilico
MX5681E (es)	1983-12-08	Procedimiento para la preparacion de esteres de acido o-(piridiloxi-fenil)-lactico
ES490729A0 (es)	1981-04-16	Procedimiento para la preparacion de nuevas imidas de acido ciclobutandicarboxilico
AR227884A1 (es)	1982-12-30	Procedimiento para la obtencion de acido(fenil-2-benzotiazolil-6)-2-propionico
AR225292A1 (es)	1982-03-15	Procedimiento para preparar derivados de acido 6-halogeno-alfametil carbazol-2-acetico
IT1164096B (it)	1987-04-08	Procedimento per la preparazione di acido ursodesossiclico
ES529350A0 (es)	1985-08-01	Procedimiento para la preparacion de derivados de acido 5-fenilcarbamoilbarbiturico
MX5206E (es)	1983-04-25	Procedimiento para la preparacion de fenoxi-alfa-vinil-bencil-esteres de acido ciclopropancarboxilico
ES491601A0 (es)	1981-05-16	Procedimiento para la preparacion de derivados de acido n-acil-amino
AR223209A1 (es)	1981-07-31	Procedimiento para la preparacion de acido metacrilico
AR225776A1 (es)	1982-04-30	Un procedimiento para la preparacion de acido 9-oxo-11 alfa-hidroxi-15-metanosulfonamido-16-genoxi-cis-5 w-omega-tetranor prostenoico
MX5329E (es)	1983-06-22	Procedimiento para la preparacion de alcoxialquil amidas de acido 4-(p-trifluorometilfenoxi)-alfa-fenoxipropionico
AR218294A1 (es)	1980-05-30	Procedimiento para la preparacion de derivados de acido oleanoico
MX5372E (es)	1983-06-30	Procedimiento para la preparacion de cianometilester de acido 4-(p-trifluorometil fenoxi)-alfa-fenoxipropionico
ES489318A0 (es)	1982-07-01	Procedimiento para la obtencion de compuestos de acido 17-c-esteroide- -propionico
ES489119A0 (es)	1981-03-16	Un procedimiento para la preparacion de acido 6-cloro-alfa- metil-carbazol-2-acetico
ES496428A0 (es)	1981-10-01	Procedimiento para la preparacion de cloruro de acido g-clo-roacetoacetico
IT1166769B (it)	1987-05-06	Procedimento per la preparazione di acido tereftalico